Biocon MD and CEO Siddharth Mittal on May 24 said that the Chinese market has become the biggest pharmaceutical market after the United States and went on to say that Indian Pharma companies are seeing very big market opportunity in China. He said, “Asked how Biocon sees China as a market, he said the company has already filed applications for a few molecules in China and also is in talks with local companies for partnerships to sell drugs. If we see, China is the biggest pharmaceutical market after the US. We are seeing many changes in the China market which earlier was a very strong retail branded market. Due to government procurement, it is going very much towards the tender system. And, the Chinese FDA (the Chinese drug regulator), they are focused on raising their standard as far as the drugs sold in that country are concerned. The regulator wants to bring it in line with the global standards.”